Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inovio Pharma (NQ: INO )

11.75 -0.35 (-2.89%)
Streaming Delayed Price Updated: 12:59 PM EDT, May 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharma

< Previous 1 2 3 4 5 6 7 8 Next >
Is Inovio Pharmaceuticals Primed For a Comeback?
The past 12 months have been tough on the vaccine maker. 
Via The Motley Fool
Exposures COVID-19
Here's Why Inovio Pharmaceuticals Soared 23% In June
Encouraging news reversed what had been a steep sell-off for the clinical-stage biotech. 
Via The Motley Fool
Exposures COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021
Upgrades Zelman upgraded the previous rating for Armstrong World Industries Inc (NYSE: 
Via Benzinga
Inovio Pharmaceuticals: Return On Capital Employed Insights
During Q1, Inovio Pharmaceuticals's (NASDAQ:INO) reported sales totaled $371.12 thousand. Despite a 79.13% in earnings, the company posted a loss of $52.55 million. In Q4, Inovio... 
Via Benzinga
Inovio Pharmaceuticals Could See a Boost from Covid-19 Partnerships
Some say INO stock could be the target of a short squeeze, but Inovio's Covid-19 vaccine program should be a sufficient reason to invest. 
Via InvestorPlace
Exposures COVID-19
Should You Buy Biotech ETFs Now?
Instead of trying to pick winners in this volatile space, it is better to invest in broader biotech ETFs that stand to benefit from increased investor interest and rising spending on drugs and... 
Via Talk Markets
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers NuCana (NASDAQ:NCNA) shares moved upwards by 16.17% to $3.16 during Thursday's regular session. NuCana's stock is trading at a volume of 4.7 million shares... 
Via Benzinga
Why Inovio Stock Is Sinking Today
Investors appear to be taking some profits after yesterday's huge gain. 
Via The Motley Fool
Exposures COVID-19
62 Biggest Movers From Yesterday
Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares surged 388.2% to close at $10.79 on Wednesday in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID... 
Via Benzinga
Twitter And Regeneron Lead The SPY In Another Mixed Day Of Trading
U.S. indices at a mixed day of trading Wednesday as investors and traders weighed the U.S. 30-Year Treasury note falling to 2.1483%,... 
Via Benzinga
Why Inovio Stock Looks Ready To Break Out, Make Bullish Reversal
Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares were trading higher Wednesday as retail traders continue to push high short interest stocks higher. The stock saw above average... 
Via Benzinga
INO Stock: 2 Big Reasons Inovio Pharmaceuticals Is Shooting Higher Today
Today, INO stock is soaring amid a recently announced expanded partnership for its Covid-19 vaccine and potential short squeeze implications. 
Via InvestorPlace
Exposures COVID-19
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Aethlon Medical (NASDAQ:AEMD) shares moved upwards by 347.96% to $9.9 during Wednesday's regular session. As of 12:30 EST, Aethlon Medical's stock is... 
Via Benzinga
Inovio Pharmaceuticals Insights: Return On Capital Employed
During Q1, Inovio Pharmaceuticals's (NASDAQ:INO) reported sales totaled $371.12 thousand. Despite a 79.13% in earnings, the company posted a loss of $52.55 million. In Q4, Inovio... 
Via Benzinga
Inovio, Advaccine to Share $100M in Cost for Late-Stage COVID-19 Vaccine Trial
Inovio Pharmaceuticals Inc (NASDAQ: INO) has expanded its partnership with Advaccine Biopharmaceuticals Suzhou Co Ltd to jointly conduct a global... 
Via Benzinga
Exposures COVID-19
48 Stocks Moving In Wednesday's Mid-Day Session
Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares jumped 371% to $10.41 in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An... 
Via Benzinga
These Vaccine Latecomers Could Still Win Big. Here's How
The key is standing out from the crowd. 
Via The Motley Fool
Topics Cannabis
Exposures COVID-19 Cannabis
Why Inovio Pharmaceuticals Stock Perked Up in May
The biotech's pan-COVID-19 vaccine caught the eye of investors last month. 
Via The Motley Fool
Exposures COVID-19
I Would Hope Inovio Isn’t Attracting ANY Serious Money
It seems as though INO stock will have a tough time getting and staying in double digits 
Via InvestorPlace
Is It Too Late to Buy Inovio Pharmaceuticals Stock?
This troubled coronavirus vaccine developer has created far more woes than joys for investors. 
Via The Motley Fool
Exposures COVID-19
Step Aside AMC: Here Are The Most Shorted Stocks Right Now
Just like in late January the common theme here is that all these stocks are extremely heavily shorted, and retail investors are seeking to squeeze the shorts once again and this time with even more... 
Via Talk Markets
Ocugen vs. Inovio: Where Is the Smart Money Going?
They're both seeking share in the vaccine market. 
Via The Motley Fool
Exposures COVID-19
Inovio's Latest COVID Vaccine Results: Too Little, Too Late?
Maybe not -- especially outside of the U.S. 
Via The Motley Fool
Exposures COVID-19
2 Things That May Boost This Beaten-Down Vaccine Stock
This company could benefit from a near-term need -- and a long-term one, as well. 
Via The Motley Fool
High Flyers At Much Lower Altitudes
Stocks with extreme valuations have taken a serious haircut since the space peaked on February 22nd. 
Via Talk Markets
1 Coronavirus Vaccine Company to Avoid Like The Plague in May (and Beyond)
This biotech's prospects look dim. 
Via The Motley Fool
Exposures COVID-19
Inovio's Pan-COVID-19 Vaccine Candidate Can Provide Immune Responses Against Variants, Animal Study Shows
Inovio Pharmaceuticals Inc (NASDAQ: INO) has announced results from a preclinical study of its next-generation Pan-COVID-19 vaccine candidate, INO-4802, that... 
Via Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
Exposures COVID-19
Stocks That Hit 52-Week Lows On Tuesday
Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... 
Via Benzinga
Novavax, Inovio Stocks Hammered As Covid Vaccine News Disappoints
Vaccine stocks crumbled Tuesday after Novavax announced a delay and Inovio's Covid vaccine disappointed in testing. Both NVAX stock and INO stock plunged. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.